Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression

Prostate

Volumn 47, Issue 1, 2001, Pages 1-13

  Webber, Mukta M ^a   Quader, Salmaan T A ^a   Kleinman, Hynda K ^b   Bello DeOcampo, Diana ^a   Storto, Patrick D ^c   Bice, Gillian ^c   Demendonca Calaca, Wanderley ^d   Williams, Daniel E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d Department of Medical Oncology and Hematology   (United States)

Author keywords

Carcinogenesis; Human cell lines; Prostate cancer; Tumor progression

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYTOKERATIN 18; CYTOKERATIN 8; METHYLNITROSOUREA; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER PREVENTION; CARCINOGENESIS; CHROMOSOME MAP; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; KARYOTYPE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM;

ALKYLATING AGENTS; ANIMALS; CARCINOGENICITY TESTS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIVISION; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; HUMANS; KERATINS; MALE; METHYLNITROSOUREA; MICE; MICE, NUDE; NANDROLONE; NEOPLASM INVASIVENESS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0035313564     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1041     Document Type: Article

References (43)

1. Cancer statistics, 2000. CA
2. Numerical chromosomal anomalies in latent adeno-carcinoma of the prostate
3. Early detection of prostate cancer
4. Prostatic intraepithelial neoplasia is a risk factor for cancer
5. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients
6. Defeating prostate cancer: Crucial directions for research. Excerpts from the report of the prostate cancer progress review group
7. High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer
8. Development, progression, and androgen dependence of prostate tumors in probasin-large T antigen transgenic mice. A model for prostate cancer
9. Expression of early growth response genes in human prostate cancer
10. Immortalized and tumorigenic adult human prostatic epithelial cell lines. Characteristics and applications. Part 1. Cell markers and immortalized nontumorigenic cell lines
11. Immortalized and tumorigenic adult human prostatic epithelial cell lines. Characteristics and applications. Part 2. Tumorigenic cell lines
12. High-malignancy orthotopic nude mouse model of human prostate cancer LNCaP
13. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18
14. Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells
15. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid
16. Lobund-Wistar rat model of prostate cancer in man
17. Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea
18. Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea
19. In vitro malignant conversion of low-grade rat urinary bladder carcinoma cells by exposure to N-methyl-N-nitrosourea
20. Normal, benign and malignant human prostatic epithelium. In vitro cell models for studies on the etiology, treatment and prevention of benign and malignant human prostatic neoplasia
21. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line
22. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
23. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel
24. Ras activation of human prostate epithelial cells induces overexpression of parathyroid hormone-related peptide
25. Synergistic effect of MNU and DMBA in mammary carcinogenesis and H-ras activation in female Sprague-Dawley rats
26. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro
27. Gradation of carcinogen-induced capacity for anchorage independent growth of cultured rat liver epithelial cells
28. Chromosomal clues to the development of prostate tumors
29. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer
30. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis
31. Allelic loss on chromosome 8p, 22q and 18q (DCC) in human prostate cancer
32. Chromosomal basis of adenocarcinoma of the prostate
33. Mutations and expression analysis of the p73 gene in prostate cancer
34. Laminin-1 and α6β1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells
35. Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone
36. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials
37. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl) retinamide
38. Modulation of the malignant phenotype of human prostatic cancer cells by N-(4-hydroxyphenyl) retinamide (4-HPR)
39. Regulation of prostatic growth function by peptide growth factors
40. Recent advances in chemoprevention of cancer
41. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
42. A human prostatic stromal myofibroblast cell line WPMY-1: A model for stromal-epithelial interactions in prostatic neoplasia